Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 4M | 3M | 5M | 4M | 3M | 4M |
| Cost of revenue | 4M | 3M | 4M | 3M | 3M | 4M |
| Gross profit | 196,337 | −45,229 | 654,053 | 537,114 | −145,657 | 202,340 |
| Research and development | — | — | — | — | 89,403 | 344,784 |
| Selling, general and administrative | 860,551 | 650,728 | 605,273 | 598,552 | 764,757 | 755,959 |
| Operating expenses | 2M | 3M | 2M | 2M | 3M | 5M |
| Operating income | −2M | −3M | −2M | −2M | −3M | −5M |
| Income tax | — | — | — | — | 0 | 0 |
| Net income | −2M | −3M | −2M | −2M | −3M | −5M |
| Earnings per share | −12.93 | −1.23 | −0.87 | −1.08 | −2.64 | −3.09 |
| Earnings per share, diluted | −12.93 | −1.23 | −0.87 | −1.08 | −2.64 | −3.09 |
| Weighted average shares | 161,925 | 2M | 2M | 1M | 952,000 | 952,000 |
| Weighted average shares, diluted | 161,925 | 2M | 2M | 1M | 952,000 | 952,000 |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | 1M | — | — | — | 7M | 11M | 14M |
| Short-term investments |
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | −2M | — | — | −2M | — | — |
| Depreciation and amortisation | 467,161 | 419,825 | 425,551 | 441,672 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| — |
| — |
| — |
| — |
| — |
| 0 |
| 995,208 |
| Receivables | 583,292 | — | 312,993 | — | 198,829 | 0 | 129,544 | 115,793 |
| Inventory | 3M | 2M | 2M | 3M | 2M | 3M | 3M | 4M |
| Current assets | 10M | 5M | 10M | 13M | 12M | 10M | 15M | 20M |
| Property, plant and equipment | 8M | 8M | 9M | 9M | 11M | 15M | 14M | 14M |
| Total assets | 23M | 16M | 19M | 22M | 24M | 26M | 30M | 34M |
| Current liabilities | 3M | 2M | 2M | 3M | 3M | 4M | 4M | 5M |
| Total liabilities | 6M | 3M | 3M | 4M | 6M | 7M | 7M | 8M |
| Equity | 17M | 13M | 16M | 19M | 18M | 19M | 23M | 26M |
| Shares outstanding | 529,330 | 2M | 2M | 2M | 1M | 1M | 10M | 10M |
| Shares issued | 529,330 | 2M | 2M | 2M | 1M | 1M | 10M | 10M |
| 440,458 |
| 434,958 |
| Share-based compensation | 74,925 | — | — | 55,968 | — | — |
| Capital expenditure | 108,661 | — | — | 828,861 | — | — |
| Investing cash flow | −108,661 | — | — | −789,774 | — | — |
| Financing cash flow | 6M | — | — | −54,806 | — | — |